School of Medicine
  • Print

Professor Jon Arcelus appointed as co-chair of the global Standards of Care for Transgender People of the World Professional Association of Transgender Health


Congratulations to Jon Arcelus, Professor in Youth Mental Health and Transgender Health at the University of Nottingham School of Medicine, who has been appointed as co-chair of the global Standards of Care for Transgender People of the World under the World Professional Association for Transgender Health (WPATH).

Jon will join Co-Chair, Dr Asa Radix from NYU, and Chair, Dr Eli Coleman from the University of Minnesota Medical School in Minneapolis, in leading the process for the SOC8 Revision Committee.


SOC8 Revision Committee process


After completing his undergraduate degree in Medicine in Spain, Jon moved to the United Kingdom to train as a psychiatrist and worked specifically with young people and families. He also trained in Sexual Health, as well as in Psychotherapy, primarily Interpersonal and Systemic. During his training years, Jon worked at the Gender Identity Development Service (GIDS) in London. He subsequently obtained a Master’s degree in Sexology at Sheffield University and a PhD in Primary Health Care at Leicester University in the United Kingdom. Jon currently works clinically at the Nottingham Centre for Transgender Health in the UK and he holds the first Chair in Transgender Health in the UK at the University of Nottingham, part of the Russell Group. Jon is the author of more than 100 peer-reviewed publications, book chapters and books. He is a PhD supervisor at the University of Nottingham, Loughborough University, and the University of Barcelona, where he holds honorary contracts. He has particular expertise in undertaking systematic literature reviews and meta-analysis. He is an Associate Editor of two international journals, including the International Journal of Transgenderism.





Posted on Monday 31st July 2017

School of Medicine

University of Nottingham
Medical School
Nottingham, NG7 2UH

Contacts: Please see our 'contact us' page for further details